M S Simberkoff

624 total citations
8 papers, 470 citations indexed

About

M S Simberkoff is a scholar working on Pharmacology, Molecular Medicine and Infectious Diseases. According to data from OpenAlex, M S Simberkoff has authored 8 papers receiving a total of 470 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pharmacology, 4 papers in Molecular Medicine and 2 papers in Infectious Diseases. Recurrent topics in M S Simberkoff's work include Antibiotics Pharmacokinetics and Efficacy (4 papers), Antibiotic Resistance in Bacteria (4 papers) and Bacterial Identification and Susceptibility Testing (2 papers). M S Simberkoff is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (4 papers), Antibiotic Resistance in Bacteria (4 papers) and Bacterial Identification and Susceptibility Testing (2 papers). M S Simberkoff collaborates with scholars based in United States. M S Simberkoff's co-authors include Gerald Schiffman, James J. Rahal, Indravadan H. Patel, Antonia Kolokathis, John C. Pottage, Robert H.K. Eng, P. K. Sharkey, Thomas F. Patterson, Rajnish K. Gupta and J. Stuart Wolf and has published in prestigious journals such as The Lancet, Clinical Infectious Diseases and Antimicrobial Agents and Chemotherapy.

In The Last Decade

M S Simberkoff

8 papers receiving 432 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M S Simberkoff United States 8 282 209 123 60 38 8 470
José L. Bran United States 11 270 1.0× 237 1.1× 117 1.0× 62 1.0× 16 0.4× 12 498
H.A. Verbrugh Netherlands 10 183 0.6× 165 0.8× 95 0.8× 52 0.9× 33 0.9× 20 458
R Fujii Japan 11 240 0.9× 246 1.2× 116 0.9× 61 1.0× 12 0.3× 88 578
Jacobo Sabbaj Guatemala 10 159 0.6× 148 0.7× 78 0.6× 56 0.9× 13 0.3× 13 389
Conrad J. Wilkowske United States 14 309 1.1× 192 0.9× 87 0.7× 77 1.3× 20 0.5× 33 569
William J. Holloway United States 13 318 1.1× 299 1.4× 112 0.9× 82 1.4× 10 0.3× 29 581
Nabil I. Girgis Egypt 11 429 1.5× 201 1.0× 62 0.5× 62 1.0× 52 1.4× 25 831
E Bernard France 13 204 0.7× 180 0.9× 204 1.7× 95 1.6× 17 0.4× 53 556
Robert Libke United States 13 285 1.0× 309 1.5× 204 1.7× 98 1.6× 9 0.2× 23 609
D. N. Gerding United States 9 286 1.0× 319 1.5× 76 0.6× 80 1.3× 23 0.6× 11 505

Countries citing papers authored by M S Simberkoff

Since Specialization
Citations

This map shows the geographic impact of M S Simberkoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M S Simberkoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M S Simberkoff more than expected).

Fields of papers citing papers by M S Simberkoff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M S Simberkoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M S Simberkoff. The network helps show where M S Simberkoff may publish in the future.

Co-authorship network of co-authors of M S Simberkoff

This figure shows the co-authorship network connecting the top 25 collaborators of M S Simberkoff. A scholar is included among the top collaborators of M S Simberkoff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M S Simberkoff. M S Simberkoff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Kovacs, Andrea, Howard L. Leaf, & M S Simberkoff. (1997). BACTERIAL INFECTIONS. Medical Clinics of North America. 81(2). 319–343. 17 indexed citations
2.
Sharkey, P. K., John R. Graybill, Richard B. Pollard, et al.. (1996). Amphotericin B Lipid Complex Compared with Amphotericin B in the Treatment of Cryptococcal Meningitis in Patients with AIDS. Clinical Infectious Diseases. 22(2). 308–314. 146 indexed citations
3.
Simberkoff, M S, et al.. (1986). Bactericidal activity of ciprofloxacin against amikacin- and cefotaxime-resistant gram-negative bacilli and methicillin-resistant staphylococci. Antimicrobial Agents and Chemotherapy. 29(6). 1098–1100. 16 indexed citations
5.
Patel, Indravadan H., et al.. (1982). Pharmacokinetic characteristics of intravenous ceftriaxone in normal adults. Antimicrobial Agents and Chemotherapy. 22(5). 816–823. 89 indexed citations
6.
Simberkoff, M S, et al.. (1982). Efficacy of a twelve-hourly ceftriaxone regimen in the treatment of serious bacterial infections. Antimicrobial Agents and Chemotherapy. 22(1). 103–107. 24 indexed citations
7.
Simberkoff, M S, et al.. (1975). R FACTORS IN GENTAMICIN-RESISTANT ORGANISMS CAUSING HOSPITAL INFECTION. The Lancet. 306(7946). 1176–1178. 20 indexed citations
8.
Simberkoff, M S, et al.. (1974). DRUG-ASSOCIATED DIARRHŒA AS A POTENTIAL RESERVOIR FOR HOSPITAL' INFECTIONS. The Lancet. 303(7868). 1195–1196. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026